Home | Links | Contact Us | More About Intellectual Property | Bookmark
Search patents:
Home Vasodialators Use-of-fedotozine-in-the-treatment-of-functional-states-of-intestinal-obstructions

 Microbial hair tonic composition
We claim: 1. A microbial hair treatment composition comprising 10.sup.6 to 10.sup.8 cells/ml of ...


 Hair treating composition
OF THE INVENTION The formulation of 9 parts d-panthenyl ethyl ether and 1 part d-panthenol can be ...


 Hair cosmetic composition
We claim: 1. A composition of matter in the form of a solution, comprising: (a) a solvent including ...


 Anti-thrombogenic, anti-microbial compositions containing heparin
OF THE INVENTION The compositions of the present invention are first dissolved in solvent mixtures ...


 Derivative-compound-conjugates and pharmaceutical compositions comprising same
OF THE INVENTION The introduction of molecules of diagnostic, prophylactic, or therapeutic ...


 Vincamine derivatives and process for the preparation of vincamine and derivatives thereof
Having now described our invention what we claim as new and desire to secure by Letters Patent is: 1...


 Naphthyridine derivatives and their use as anti-bacterials
What we claim is: 1. A 1,8-naphthyridine compound of the formula ##STR9## wherein R is vinyl or 2-...


 Indole derivatives
We claim: 1. A compound of formula (I) ##STR11## wherein R.sup.1 and R.sup.2 each represents a ...


 4-(3-(4-Quinolyl)propyl)piperidines, their preparation and their use as medicines
What is claimed is: 1. A method for the treatment of a mammal afflicted with a disturbance in the ...


 Derivatives of 1-(2-,3- or 4-quinolyl)-2- or -3-(2- or 3-piperidyl or -pyrrolidinyl) ethanone or propanone, and their utilization as antiarrhythmics, anticonvulsivants and for the treatment of anxiety
What is claimed is: 1. Compounds of the formula: ##STR30## in which R is fixed in position 2 or 4 ...


 Use of fedotozine in the treatment of functional states of intestinal obstructions

Details
Inventors: Riviere, Pierre J. M.; Pascaud, Xavier B.; Roman, Francois J.; Junien, Jean-Louis;
Assignee:
Primary Examiner: Cintins; Marianne M.
Assistant Examiner: Jarvis; William R. A.
Attorney, Agent or Firm:

A process for inhibiting functional ileus in a patient, which consists of administering a therapeutically effective dose of (+)-1-1[(3,4,5-trimethoxy)benzyloxymethyl]-1-phenyl-N,N dimethylpropylamine or the addition salt thereof with (-)-tartaric acid is disclosed.

DETAILED DESCRIPTION We claim: 1.
Process for inhibiting functional ileus in a patient, which consists of administering a therapeutically effective dose of (+)-1-[(3,4,5-trimethoxy)benzyloxymethyl]-1-phenyl-N,N-dimethylpropylamine or the addition salt thereof with (-)-tartaric acid.
2.
Process according to claim 1, in which the functional ileus is postoperative.
3.
Process according to claim 1, in which the functional ileus is of pseudo-obstructive origin.
4.
Process according to claim 1 which consists in administering a daily dose of 5 to 1000 mg to the patient.
5.
Process according to claim 1, which consists in administering the substance by injection.
6.
Process according to claim 1, which consists in administering the substance by perfusion.




Description:
In gastroenterology it is known that functional occlusions observed at different stages of the gastrointestinal tract result in a motor paralysis of the digestive tract.
These states, known as ileus, are always observed, inter alia, after certain surgical operations, especially laparotomies.
They may also be encountered in localised functional occlusive disorders such as pseudo obstructions of the colon (Ogilvie syndrome), more extensive occlusions such as chronic iodapathic pseudo obstruction which corresponds to a true gastrointestinal paralysis, or in various retroperitoneal disorders such as nephritic colics, in which persistent ileus may be established, linked with peritoneal irritation.
Whatever the ethiologic circumstances, these ileus result in a build-up of gases and secretions which cause painful abdominal meteorism, nausea and vomiting in the patient.
A distinction is drawn depending on the duration of these states, which is about 72 hours for "simple" or "physiologic" post-operative ileus and up to several weeks for cases of paralytic ileus where an underlying trouble, for instance a hydroelectric trouble should be investigated.
The latter cases are the more serious and the patent frequently has respiratory problems linked with the meteorism and the conditions of dehydration for which the symptomatic medical treatment in a hospital environment consists of inserting a nasointestinal tube, in conjunction with rehydration of the patient by intravenous route until the ileus is resolved



Related patents
  Manufacture of pharmaceutical dosage forms
OF THE INVENTION The present invention is directed to solid, unit dosage forms primarily for oral ingestion which are advantageous in a number of particulars over ...
  Device comprising liner for protecting fluid sensitive medicament
OF THE DRAWING FIGURES Turning now to the drawings in detail, which are examples of various delivery devices provided by the invention and which examples are not to be ...
  In situ active compound assembly
I claim: 1. A method to modify a target condition contained within an environment with a conjugate active in modifying said target condition which conjugate comprises at ...
  Inhibition of nitric oxide-mediated hypotension and septic shock with iron-containing hemoprotein
The invention is directed to a method for the prophylaxis or treatment of an animal for systemic hypotension or other pathogenic syndromes induced by inappropriate ...
  Use of cardiotonic drugs and inhibitors of nitric oxide synthesis to alleviate pathologic hypotension
The present invention involves a method for prophylaxis or treatment of an animal for systemic hypotension induced by endotoxin and/or a biological response modifier ...
  Anti-endotoxin, interleukin-1 receptor antagonist and anti-tumor necrosis factor antibody with arginine-free formulations for the treatment of hypotension
The inventors herein propose uses of anti-TNF antibodies, anti-endotoxin antibodies, and cytokine receptor antagonists (e.g., IL-1 receptor antagonist) in combination ...
  Anti-bronchoconstriction 2-(4'-pyridinyl)-thiazole derivatives, composition, and method of use therefor
We claim: 1. A compound having the structural formula I ##STR4## wherein R is cyano, ##STR5## --C(.dbd.X)NHY wherein X is O, S or NH; and Y is hydrogen, hydroxy, alkyl ...
  Aromatic benzamido compounds; their preparation and their use in human or veterinary medicine or in cosmetic preparations
What is claimed is: 1. A pharmaceutical composition comprising in a vehicle suitable for enteral, parenteral, topical or ocular administration, at least one aromatic ...
  Antioxidant-induced apoptosis in vascular smooth muscle cells
The invention is based on the discovery that, unlike other cell types, vascular smooth muscle cells which contribute to the development of arteriosclerosis are induced ...
  Treatment of climacteric disorders with nitric oxide synthase substrates and/or donors
In a method aspect, this invention relates to a method of treating the climacterium symptoms in a non-pregnant female or in a male mammal which comprises administering ...

0.004

Archive: All patents - Links

Copyright (c)2006 Eipa-patents.org - All rights reserved